The Commercialization Grant provides funds to accelerate the development of promising technology (device, software, smartphone app, therapeutic, or diagnostic) originating from the university and/or college sector and promote its transfer into the Canadian healthcare environment. The Commercialization Grant provides funding to CANet Network Investigators or CHAT Members to support research and development projects with recognized technology transfer potential.
This is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection. All commercialization activities must help CANet meet its 10-20-30 goals as described in the 2016-2019 Strategic Plan.
Up to $150,000 for a duration of max. 1 year is available to support the commercialization activities in areas aligned with CANet’s strategic priorities of Network Investigators and CHAT Members. Matching partner contributions are preferred but not required. A maximum of one commercialization grant can be held at any one time by a Network Investigator or CHAT Member.
Every CANet-funded project includes a patient partner. Patients are represented on every CANet committee. From governance to research to disease management, patients are co-leaders in CANet.
